Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Mirum Pharmaceuticals (MIRM) Interest Coverage Ratio (2020 - 2025)

Historic Interest Coverage Ratio for Mirum Pharmaceuticals (MIRM) over the last 6 years, with Q3 2025 value amounting to 0.72.

  • Mirum Pharmaceuticals' Interest Coverage Ratio rose 12040.81% to 0.72 in Q3 2025 from the same period last year, while for Sep 2025 it was 2.91, marking a year-over-year increase of 5668.09%. This contributed to the annual value of 6.12 for FY2024, which is 1528.8% up from last year.
  • As of Q3 2025, Mirum Pharmaceuticals' Interest Coverage Ratio stood at 0.72, which was up 12040.81% from 1.39 recorded in Q2 2025.
  • In the past 5 years, Mirum Pharmaceuticals' Interest Coverage Ratio registered a high of 0.72 during Q3 2025, and its lowest value of 14.08 during Q1 2021.
  • For the 5-year period, Mirum Pharmaceuticals' Interest Coverage Ratio averaged around 7.0, with its median value being 7.4 (2024).
  • Its Interest Coverage Ratio has fluctuated over the past 5 years, first tumbled by 1669.66% in 2023, then soared by 12040.81% in 2025.
  • Quarter analysis of 5 years shows Mirum Pharmaceuticals' Interest Coverage Ratio stood at 12.1 in 2021, then skyrocketed by 35.24% to 7.84 in 2022, then fell by 16.7% to 9.15 in 2023, then rose by 26.0% to 6.77 in 2024, then skyrocketed by 110.67% to 0.72 in 2025.
  • Its Interest Coverage Ratio stands at 0.72 for Q3 2025, versus 1.39 for Q2 2025 and 4.22 for Q1 2025.